PSFS

10xBio Announces Data from Interim Analysis of Phase 2b Clinical Trial Showing Superior Efficacy of Novel Drug for Submental Body Contouring

Retrieved on: 
Monday, March 11, 2024
CSFS, PSFS, Biotechnology, Elective surgery, Bruise, Patient, SAN, Abdomen, American Academy, MD, Clinician, Clinical trial, American Academy of Dermatology, Erythema, ITT, FAAD, Pain, AAD, FDA, Organic acid, Edema, Annual general meeting, Pharmaceutical industry

SAN DIEGO, March 11, 2024 /PRNewswire/ -- 10xBio, LLC, a biotechnology company that focuses on new uses for existing therapies and technologies, announced today promising initial clinical trial results on its novel injectable drug for submental body contouring, 10XB101. An innovative alternative to other fat removal options, 10XB101 provides superior efficacy, fewer side effects, enhanced patient tolerability and shorter treatment intervals.

Key Points: 
  • SAN DIEGO, March 11, 2024 /PRNewswire/ -- 10xBio , LLC, a biotechnology company that focuses on new uses for existing therapies and technologies, announced today promising initial clinical trial results on its novel injectable drug for submental body contouring, 10XB101.
  • An innovative alternative to other fat removal options, 10XB101 provides superior efficacy, fewer side effects, enhanced patient tolerability and shorter treatment intervals.
  • "10XB101 has the appropriate product-market fit to capture the tremendous opportunity for submental contouring.
  • In addition, its attributes hold promise for potential expansion to other body contouring applications, such as treatment of the abdomen and flanks."

Crossover Health Shares New Research at ATA 2023 on Virtual PT and Hybrid Care

Retrieved on: 
Friday, March 3, 2023
Integration, Population Health Management, DPT, Conference, Virtual, Education, System, SAN, Value, Population health, Goodness, PSFS, Glossary, Research, GOF, Therapeutic alliance, Nursing, MD

Crossover Health Medical Group leaders will unveil research results pertaining to areas experiencing limited study: comparing virtual care to in-person care and the value of hybrid care for population health management.

Key Points: 
  • Crossover Health Medical Group leaders will unveil research results pertaining to areas experiencing limited study: comparing virtual care to in-person care and the value of hybrid care for population health management.
  • "The Value of Integrating In-person and Virtual Care for Population Health Management in Employer-Sponsored Primary Care Settings," will be presented by Yvonne Robinson-Hawkins, MD, National Virtual Care Team Physician at Crossover Health.
  • Results found that outcomes improved under a hybrid care model, which offers flexibility and choice in addressing population health needs.
  • Crossover Health has been an industry leader in the delivery of both virtual and onsite care through its unique and highly effective hybrid care approach.

Guidehouse Announces Organizational Updates in 2023

Retrieved on: 
Thursday, December 22, 2022
FS, PSFS, ES, SLG, FFI, Rivers State Local Government Service Commission, Environment, Capital market, Transport, The, Growth, Defense Criminal Investigative Service, Commercial bank, McIntyre, Consultant, State, Lead, Economic development, Sustainability, GIC, Culture, Financial crime, New Year, Public sector, Veritas Capital, Audit, Renewable energy, Insurance

WASHINGTON, Dec. 22, 2022 /PRNewswire/ -- Guidehouse , a leading global provider of consulting and managed services to public sector and commercial clients, today announces organizational updates moving into the New Year.

Key Points: 
  • WASHINGTON, Dec. 22, 2022 /PRNewswire/ -- Guidehouse , a leading global provider of consulting and managed services to public sector and commercial clients, today announces organizational updates moving into the New Year.
  • The changes, effective as of January 1, 2023, signify the strategic steps Guidehouse is taking in the company's evolution.
  • "As we move into 2023, these changes will enhance our capabilities to address clients' complex issues, promote quality, and create opportunities for our people."
  • Our new dedicated FFI business will serve clients across all Guidehouse segments and will be led by Ellen Zimiles, previously Guidehouse FS segment lead.